Therapeutic peptides: Historical perspectives, current development trends, and future directions

Area of Science:

• * Pharmacology and Drug Development
• * Medicinal Chemistry
• * Biotechnology

Background:

• * Peptide therapeutics have a long history in medicine, starting with insulin in the 1920s.
• * Over 60 peptide-based drugs are currently approved in major markets.
• * The field is expanding, with a consistent flow of new peptide candidates entering clinical trials.

Purpose of the Study:

• * To provide a comprehensive overview of the current peptide therapeutic landscape.
• * To analyze historical trends, molecular characteristics, and regulatory aspects of peptide drugs.
• * To break down the development of peptide therapeutics by therapeutic area.

Main Methods:

• * Compilation and analysis of a comprehensive dataset of peptides that have entered human clinical studies.
• * Review of historical data and regulatory benchmarks for peptide therapeutics.
• * Categorization of active peptide development candidates by therapeutic area.

Main Results:

• * Over 150 peptides are currently in active clinical development.
• * Peptide drug discovery has broadened beyond endogenous human peptides to include diverse structures.
• * Significant progress has been made across various therapeutic areas.

Conclusions:

• * Peptide therapeutics represent a dynamic and growing sector in drug development.
• * The diversification of peptide sources and ongoing research support continued innovation.
• * The landscape analysis offers valuable insights for researchers and developers in the field.